BOK Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.2M | Sell |
136,461
-21,809
| -14% | -$2.87M | 0.24% | 84 |
|
|
2026
Q1 | $22.1M | Buy |
158,270
+42,516
| +37% | +$5.95M | 0.34% | 63 |
|
|
2025
Q4 | $14.2M | Buy |
115,754
+1,998
| +2% | +$243K | 0.22% | 91 |
|
|
2025
Q3 | $12.6M | Buy |
113,756
+9,926
| +10% | +$1.13M | 0.19% | 107 |
|
|
2025
Q2 | $11.5M | Sell |
103,830
-877
| -0.8% | -$93.3K | 0.19% | 106 |
|
|
2025
Q1 | $11.7M | Sell |
104,707
-3,834
| -4% | -$396K | 0.21% | 97 |
|
|
2024
Q4 | $9.76M | Buy |
108,541
+1,966
| +2% | +$177K | 0.16% | 115 |
|
|
2024
Q3 | $8.97M | Sell |
106,575
-5,959
| -5% | -$455K | 0.16% | 131 |
|
|
2024
Q2 | $7.72M | Sell |
112,534
-11,899
| -10% | -$794K | 0.14% | 146 |
|
|
2024
Q1 | $9.07M | Buy |
124,433
+9,276
| +8% | +$713K | 0.17% | 130 |
|
|
2023
Q4 | $9.33M | Sell |
115,157
-1,341
| -1% | -$104K | 0.18% | 119 |
|
|
2023
Q3 | $9.15M | Buy |
116,498
+4,529
| +4% | +$348K | 0.2% | 111 |
|
|
2023
Q2 | $8.63M | Sell |
111,969
-3,813
| -3% | -$304K | 0.18% | 127 |
|
|
2023
Q1 | $9.61M | Sell |
115,782
-6,567
| -5% | -$544K | 0.2% | 114 |
|
|
2022
Q4 | $10.5M | Sell |
122,349
-1,982
| -2% | -$157K | 0.19% | 113 |
|
|
2022
Q3 | $7.67M | Sell |
124,331
-8,982
| -7% | -$566K | 0.16% | 138 |
|
|
2022
Q2 | $8.24M | Buy |
133,313
+896
| +0.7% | +$55.5K | 0.16% | 145 |
|
|
2022
Q1 | $7.87M | Buy |
132,417
+9,630
| +8% | +$616K | 0.13% | 164 |
|
|
2021
Q4 | $8.91M | Buy |
122,787
+50,642
| +70% | +$3.49M | 0.14% | 159 |
|
|
2021
Q3 | $5.04M | Buy |
+72,145
| New | +$5.07M | 0.09% | 225 |
|
|
2021
Q1 | $3.92M | Sell |
60,628
-41,008
| -40% | -$2.64M | 0.07% | 261 |
|
|
2020
Q4 | $5.92M | Sell |
101,636
-37,585
| -27% | -$2.27M | 0.11% | 181 |
|
|
2020
Q3 | $8.8M | Sell |
139,221
-21,265
| -13% | -$1.47M | 0.19% | 116 |
|
|
2020
Q2 | $12.3M | Buy |
160,486
+35,394
| +28% | +$2.71M | 0.29% | 85 |
|
|
2020
Q1 | $9.35M | Sell |
125,092
-10,213
| -8% | -$706K | 0.27% | 94 |
|
|
2019
Q4 | $8.79M | Buy |
135,305
+2,606
| +2% | +$170K | 0.2% | 122 |
|
|
2019
Q3 | $8.41M | Buy |
132,699
+36,348
| +38% | +$2.38M | 0.2% | 113 |
|
|
2019
Q2 | $6.51M | Buy |
96,351
+108
| +0.1% | +$7.11K | 0.16% | 161 |
|
|
2019
Q1 | $6.26M | Buy |
96,243
+7,078
| +8% | +$470K | 0.15% | 159 |
|
|
2018
Q4 | $5.58M | Sell |
89,165
-18,222
| -17% | -$1.27M | 0.16% | 143 |
|
|
2018
Q3 | $8.29M | Sell |
107,387
-13,548
| -11% | -$1.02M | 0.21% | 113 |
|
|
2018
Q2 | $8.57M | Buy |
120,935
+2,146
| +2% | +$152K | 0.23% | 106 |
|
|
2018
Q1 | $8.96M | Sell |
118,789
-1,005
| -0.8% | -$79.9K | 0.25% | 97 |
|
|
2017
Q4 | $8.58M | Buy |
119,794
+21,768
| +22% | +$1.65M | 0.24% | 106 |
|
|
2017
Q3 | $7.94M | Buy |
98,026
+48,634
| +98% | +$3.72M | 0.23% | 105 |
|
|
2017
Q2 | $3.5M | Sell |
49,392
-5,914
| -11% | -$394K | 0.11% | 210 |
|
|
2017
Q1 | $3.76M | Sell |
55,306
-1,573
| -3% | -$111K | 0.12% | 198 |
|
|
2016
Q4 | $4.07M | Sell |
56,879
-1,956
| -3% | -$145K | 0.13% | 175 |
|
|
2016
Q3 | $4.66M | Sell |
58,835
-2,134
| -4% | -$173K | 0.15% | 154 |
|
|
2016
Q2 | $5.09M | Sell |
60,969
-3,378
| -5% | -$300K | 0.18% | 127 |
|
|
2016
Q1 | $5.91M | Buy |
64,347
+230
| +0.4% | +$20.7K | 0.21% | 110 |
|
|
2015
Q4 | $6.49M | Sell |
64,117
-22,857
| -26% | -$2.38M | 0.23% | 102 |
|
|
2015
Q3 | $8.54M | Sell |
86,974
-3,002
| -3% | -$333K | 0.32% | 72 |
|
|
2015
Q2 | $10.5M | Buy |
89,976
+12,906
| +17% | +$1.41M | 0.36% | 67 |
|
|
2015
Q1 | $7.56M | Buy |
77,070
+10,991
| +17% | +$1.12M | 0.25% | 95 |
|
|
2014
Q4 | $6.23M | Sell |
66,079
-10,091
| -13% | -$1.04M | 0.22% | 112 |
|
|
2014
Q3 | $8.11M | Sell |
76,170
-11,991
| -14% | -$1.17M | 0.27% | 85 |
|
|
2014
Q2 | $7.31M | Buy |
88,161
+7,434
| +9% | +$579K | 0.23% | 95 |
|
|
2014
Q1 | $5.72M | Buy |
80,727
+28,094
| +53% | +$2.2M | 0.19% | 123 |
|
|
2013
Q4 | $3.95M | Buy |
52,633
+8,227
| +19% | +$573K | 0.13% | 166 |
|
|
2013
Q3 | $2.79M | Buy |
44,406
+15,624
| +54% | +$934K | 0.1% | 221 |
|
|
2013
Q2 | $1.48M | Buy |
+28,782
| New | +$1.5M | 0.06% | 326 |
|
Other funds holding GILD
BOK Financial's GILD Position: Q2 2026 in Review
BOK Financial reduced its Gilead Sciences (GILD) stake by 14% in Q2 2026, selling an estimated $2.87M and leaving 136,461 shares worth $17.2M. The position accounts for 0.24% of the portfolio, ranked #84.
BOK Financial first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.1M in Q1 2026. 2,265 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- BOK Financial held 136,461 shares of Gilead Sciences worth $17.2M as of Q2 2026.
- BOK Financial sold 21,809 Gilead Sciences shares in Q2 2026, an estimated $2.87M.
- Gilead Sciences made up 0.24% of BOK Financial's portfolio in Q2 2026, its #84 holding.
- BOK Financial first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- BOK Financial's Gilead Sciences position peaked at $22.1M in Q1 2026.
- 2,265 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.